NSETrading Window30 Sept 2026 · 30 Sept 2026, 09:40 am
Trading Window
Divi's Laboratories Limited · DIVISLAB
✦ AI Summary
Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
DIVISLAB_30092026093952_Intimation_TradingWindowClosure_Q2FY27.pdf
View document text
Date: September 30, 2026
To To
The Secretary The Secretary
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Bandra (East) Dalal Street
Mumbai – 400 051 Mumbai – 400 001
Trading Symbol: DIVISLAB Scrip Code: 532488
Dear Sir/ Madam,
Sub: Intimation of closure of Trading Window from October 01, 2026
Pursuant to the Company’s Code of Conduct to Regulate, Monitor and Report Trading by
Designated Persons, Immediate Relatives of Designated Persons and Insiders (the Code), we
hereby inform that the Trading Window for dealing in securities of the Company will remain
closed from October 01, 2026 till 48 hours after the declaration of unaudited financial results
of the Company for the quarter and half year ending September 30, 2026.
The date of Board meeting for declaration of unaudited financial results of the Company for
the quarter and half year ending September 30, 2026, will be intimated in due course.
This is for your information and records.
Thanking you,
Yours faithfully,
For Divi’s Laboratories Limited
M. Satish Choudhury
Company Secretary & Compliance Officer